Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$359M |
| 2 |
Cloudflare
NET
|
+$345M |
| 3 |
Mercado Libre
MELI
|
+$330M |
| 4 |
Amazon
AMZN
|
+$254M |
| 5 |
Joby Aviation
JOBY
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$573M |
| 2 |
Booking.com
BKNG
|
+$473M |
| 3 |
Netflix
NFLX
|
+$376M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$373M |
| 5 |
Spotify
SPOT
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.39% |
| 2 | Technology | 24.37% |
| 3 | Healthcare | 18.87% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Coherus Oncology
CHRS
$196M
| – | – |
-1,585
| Closed | -$10.8K |
|
327
Coherent
COHR
$74.2B
| – | – |
-516
| Closed | -$19.6K |
|
328
Cohu
COHU
$2.5B
| – | – |
-788
| Closed | -$30.3K |
|
329
Costco
COST
$420B
| – | – |
-78
| Closed | -$38.8K |
|
330
CrowdStrike
CRWD
$218B
| – | – |
-456
| Closed | -$15.6K |
|
331
Castle Biosciences
CSTL
$979M
| – | – |
-225
| Closed | -$5.11K |
|
332
Cognizant
CTSH
$26B
| – | – |
-214
| Closed | -$13K |
|
333
Cytokinetics
CYTK
$10.4B
| – | – |
-340
| Closed | -$12K |
|
334
Dropbox
DBX
$8.12B
| – | – |
-1,009
| Closed | -$21.8K |
|
335
Donaldson
DCI
$11.4B
| – | – |
-488
| Closed | -$31.9K |
|
336
Dollar General
DG
$27.9B
| – | – |
-72
| Closed | -$15.2K |
|
337
Quest Diagnostics
DGX
$26.3B
| – | – |
-171
| Closed | -$24.2K |
|
338
DraftKings
DKNG
$11.9B
| – | – |
-1,430
| Closed | -$27.7K |
|
339
Domo
DOMO
$184M
| – | – |
-321
| Closed | -$4.55K |
|
340
Amdocs
DOX
$6.22B
| – | – |
-432
| Closed | -$41.5K |
|
|
EA
341
DELISTED
Electronic Arts
EA
| – | – |
-207
| Closed | -$24.9K |
|
342
8x8 Inc
EGHT
$332M
| – | – |
-2,045
| Closed | -$8.53K |
|
343
Enanta Pharmaceuticals
ENTA
$400M
| – | – |
-360
| Closed | -$14.6K |
|
344
Exelixis
EXEL
$13.4B
| – | – |
-1,395
| Closed | -$27.1K |
|
345
Expeditors International
EXPD
$23.2B
| – | – |
-125
| Closed | -$13.8K |
|
346
Expedia Group
EXPE
$37.3B
| – | – |
-199
| Closed | -$19.3K |
|
347
Exponent
EXPO
$3.24B
| – | – |
-265
| Closed | -$26.4K |
|
348
Fate Therapeutics
FATE
$326M
| – | – |
-372
| Closed | -$2.12K |
|
349
Factset
FDS
$10.2B
| – | – |
-80
| Closed | -$33.2K |
|
|
KYNB
350
Kyntra Bio
KYNB
$29.4M
| – | – |
-22
| Closed | -$10.1K |
|
Similar funds
Baillie Gifford & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Baillie Gifford & Co held 461 positions worth $118B, up 6.1% from $111B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Baillie Gifford & Co's Q2 2023 filing shows 7 new, 99 increased, 159 reduced and 164 closed positions. Its largest new stake was Yeti Holdings: 3,128,447 shares worth $122M. The largest sale was Tesla, an estimated $573M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- Baillie Gifford & Co's largest Q2 2023 buy was Yeti Holdings: 3,128,447 shares worth $122M.
- Baillie Gifford & Co added most to Datadog in Q2 2023, an estimated $359M increase.
- Baillie Gifford & Co's biggest Q2 2023 reduction was Tesla, cutting an estimated $573M.
- Baillie Gifford & Co fully exited RB Global in Q2 2023, selling an estimated $86.6M.
- Baillie Gifford & Co's ten largest holdings make up 41% of its $118B portfolio in Q2 2023.
- Baillie Gifford & Co opened 7 new positions and closed 164 in Q2 2023.
- Baillie Gifford & Co's portfolio value rose 6.1% quarter-over-quarter to $118B.
Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.